Familial Frontal Fibrosing Alopecia Treated With Dutasteride, Minoxidil, and Artificial Hair Transplantation

    William Cranwell, Rodney Sinclair
    Image of study
    TLDR Treatment with dutasteride, minoxidil, and artificial hair transplantation improved appearance but caused folliculitis.
    This case report describes a premenopausal patient with familial frontal fibrosing alopecia (FFA) who was treated with dutasteride and minoxidil, which stabilized her hair loss. Artificial hair transplantation was then performed, which led to significant cosmetic improvement but also caused folliculitis. The implants were removed, and the patient became symptom-free. The report suggests that hydroxychloroquine and methotrexate play little role in preventing or altering the progression of FFA, and further research is needed to identify the optimal treatment for arresting the progressive recession of the frontotemporal hairline.
    Discuss this study in the Community →

    Research cited in this study

    11 / 11 results

    Related Community Posts Join

    6 / 261 results

      community My Theory Of Androgenic Alopecia

      in Research/Science  18 upvotes 3 days ago
      Hair loss is linked to cellular physiology and the IGF-1 to TGF-B1 ratio, not just androgen sensitivity. The theory lacks evidence, while finasteride and minoxidil are effective treatments.

      community Where to Begin with Microneedling?

      in Treatment  17 upvotes 2 years ago
      User is considering microneedling to enhance hair regrowth after limited response to minoxidil and better results with finasteride and ketoconazole shampoo. Recommendations include using a 1.5mm derma roller once a week, avoiding minoxidil on microneedling days, and disinfecting the roller with isopropyl alcohol.

      community Quote from Pelage (PP-405) Spokesperson...

      in Research/Science  121 upvotes 1 month ago
      Pelage is developing a topical hair follicle stem cell therapy, PP405, for non-scarring alopecias like androgenetic alopecia, with Phase III trials planned and a potential market launch by 2027. The treatment may not require continuous use after initial regrowth.

      community Physician here AMA – 30M oral Fin 1-1.25 mg daily

      in Update  47 upvotes 3 years ago
      Hair loss treatments, specifically the use of finasteride, microneedling and potentially oral minoxidil. People discussed their experiences with finasteride, its effects on sexual behaviors, as well as potential solutions such as tadalafil or using other growth factor signal peptides for hope in curing male pattern baldness.

    Related Research

    8 / 8 results